Premier Biomedical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	2014 - 2010
Period Ending	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	2014 - 2010
Net Income	-0.37	-0.4	-3.76	-1.77	-2.6	Upgrade
Depreciation & Amortization	0	0	0	0	0	Upgrade
Other Amortization	0.32	0.37	0.34	0.75	0.18	Upgrade
Stock-Based Compensation	-	0.3	0.78	0.11	1.85	Upgrade
Other Operating Activities	-0.35	-0.6	2.12	-0.03	0.02	Upgrade
Change in Accounts Receivable	0	-0	-0	-	-	Upgrade
Change in Inventory	0.01	-0.03	-0.08	-	-	Upgrade
Change in Accounts Payable	-0.07	-0.1	0.11	0.04	0.07	Upgrade
Change in Other Net Operating Assets	0.11	0.01	-0.02	0.41	0.02	Upgrade
Operating Cash Flow	-0.34	-0.44	-0.51	-0.48	-0.46	Upgrade
Capital Expenditures	-0	-0	-0	-0	-	Upgrade
Investing Cash Flow	-0	-0	-0	-0	-	Upgrade
Short-Term Debt Issued	0.33	0.3	0.3	0.42	0.4	Upgrade
Total Debt Issued	0.33	0.3	0.3	0.42	0.4	Upgrade
Short-Term Debt Repaid	-	-	-0.03	-0.09	-	Upgrade
Total Debt Repaid	-	-	-0.03	-0.09	-	Upgrade
Net Debt Issued (Repaid)	0.33	0.3	0.27	0.33	0.4	Upgrade
Issuance of Common Stock	-	0	0.3	0.15	0	Upgrade
Financing Cash Flow	0.33	0.45	0.57	0.47	0.4	Upgrade
Miscellaneous Cash Flow Adjustments	-	-	-0	-	-	Upgrade
Net Cash Flow	-0.02	0	0.06	-0.01	-0.07	Upgrade
Free Cash Flow	-0.35	-0.45	-0.51	-0.49	-0.46	Upgrade
Free Cash Flow Margin	-2444.02%	-1123.02%	-1282.19%	-	-	Upgrade
Free Cash Flow Per Share	-0.01	-0.13	-0.26	-0.80	-3.70	Upgrade
Cash Interest Paid	0	0	0.01	0.01	-	Upgrade
Levered Free Cash Flow	-0.31	-0.63	2.12	0.06	0.65	Upgrade
Unlevered Free Cash Flow	-0.39	-0.74	2	-0.18	0.59	Upgrade
Change in Working Capital	0.05	-0.12	0.01	0.45	0.09	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.